BJH - 2018, issue Abstract Book BHS, february 2018
S. Amat , M-C. Vekemans MD, J-P. Defour PhD, J.C. Yombi , I. Stoian , S. Bailly MD
BJH - 2018, issue Abstract Book BHS, february 2018
L. Maindiaux , F. Dall’Armellina , Y. Berners , A. Capes , V. Gillion , J. Lelotte , L. Marot , J-P. Defour PhD, M-C. Vekemans MD
BJH - 2018, issue Abstract Book BHS, february 2018
A. Capes , F. Dall’Armellina , Y. Berners , L. Maindiaux , T. Connerotte MD, A. Camboni MD, PhD, P. Saussoy MD, PhD, J-P. Defour PhD, X. Poiré MD, PhD, N. Straetmans MD, PhD, M-C. Vekemans MD
BJH - volume 8, issue 2, march 2017
M-C. Vekemans MD, K. Beel MD, PhD, J. Caers MD, PhD, N. Meuleman MD, PhD, G. Bries MD, PhD, H. Demuynck MD, B. De Prijck MD, H. De Samblanx MD, A. Deweweire MD, K. Fostier MD, A. Kentos MD, PhD, P. Mineur MD, M. Vaes MD, I. Vande Broek MD, PhD, A. Vande Velde MD, J. Van Droogenbroeck MD, P. Vlummens MD, K.L. Wu MD, PhD, R. Schots MD, PhD, M. Delforge MD, PhD, C. Doyen MD, PhD, On behalf of the Multiple Myeloma Study Group of the Belgian Haematology Society (BHS)
The prognosis for multiple myeloma patients has improved substantially over the past decade with the development of more effective chemotherapeutic agents and regimens that possess a high level of anti-tumour activity. However, nearly all multiple myeloma patients ultimately relapse, even those who experience a complete response to initial therapy. Management of relapsed disease remains a critical aspect of multiple myeloma care and an important area of ongoing research. This manuscript from the Belgian Haematology Society multiple myeloma subgroup provides some recommendations on the management of relapsed disease.
(BELG J HEMATOL 2017;8(2):53–65)
Read moreBJH - volume 8, issue Abstract Book BHS, february 2017
G. Di Prinzio , J. Devreux , S. Lefebvre , S. Bailly MD, G. Verstraete , A. Bourgois , C. Pedreira , J-P. Defour PhD, A. Camboni MD, PhD, A. Marchandise , T. Pieters , M-C. Vekemans MD
BJH - volume 8, issue Abstract Book BHS, february 2017
J. Devreux , G. Di Prinzio , S. Bailly MD, S. Lefebvre , G. Verstraete , K. van Renterghem , A. Charlot , P. Saussoy MD, PhD, J-P. Defour PhD, N. Straetmans MD, PhD, X. Poiré MD, PhD, L. Michaux MD, PhD, M-C. Vekemans MD, V. Havelange MD, PhD
BJH - volume 8, issue Abstract Book BHS, february 2017
S. Bailly MD, M-C. Vekemans MD, B. Chatelain PharmD, M. André MD, PhD, T. Vander Borght , L. D’Hondt , L. Faugeras , G. Verstraete , J. Devreux , G. Di Prinzio , S. Lefevre
Top
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.
